This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: University of Vermont. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Christopher D Huston: Innovator in Pharmaceutical Treatments
Introduction
Christopher D Huston is a notable inventor based in Burlington, VT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cryptosporidiosis. With a total of 2 patents, Huston's work focuses on innovative methods that aim to alleviate serious health conditions.
Latest Patents
Huston's latest patents include methods for treating cryptosporidiosis using triazolopyridazines. These patents detail methods for treating or providing prophylaxis for infections using compositions that include specific structures disclosed in the patents. Additionally, he has developed pharmaceutical compositions and kits designed to alleviate symptoms, treat, or prevent the occurrence of infections. The kits comprise one or more compounds with the disclosed structures, often presented in oral compositions, along with instructions for use and storage.
Career Highlights
Christopher D Huston is affiliated with the University of Vermont, where he continues to advance his research and innovations in the pharmaceutical field. His work has garnered attention for its potential impact on public health, particularly in combating infections that pose significant challenges.
Collaborations
Huston collaborates with esteemed colleagues such as Kovi Bessoff and Rajiv Satish Jumani, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Christopher D Huston exemplifies the spirit of innovation in the pharmaceutical industry, with his patents paving the way for new treatment options. His contributions are vital in addressing health challenges and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
